Literature DB >> 11602627

Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development.

K Sakashita1, K Koike, T Kinoshita, M Shiohara, T Kamijo, S Taniguchi, T Kubota.   

Abstract

We examined the kenetics of p15 methylation and expression during myeloid development. We treated human cord blood CD34+ cells with either GM-CSF alone or in combination with stem cell factor and followed methylation at this locus using bisulfite genomic sequencing. CD34+ cells were found to be either fully methylated or completely unmethylated at 27 CpG dinucleotide sites in exon 1 and at 18 CpG sites in the promoter region of the p15 gene. A time-course study showed that the percentage of the allelic methylation of p15 CpG island increased to approximately 50% to 60% until 7 days after cytokine stimulation, then decreased to less than 10% after 21 days. The methylation was also observed in bone marrow CD34+ cells exposed to GM-CSF. p15 expression varied inversely with methylation. Expression was negligible or at low levels until 14 days, after which it increased substantially. The frequency of myeloid colony-forming cells in the progeny decreased and myeloid-specific markers increased in the later stages. Based on our observations on cells grown with GM-CSF and 5-aza-2'-deoxycytidine, DNA methylation of the p15 promoter region CpG island appears to be associated with proliferation rather than differentiation of normal human myeloid progenitors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602627      PMCID: PMC209528          DOI: 10.1172/JCI13030

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  DNA methylation.

Authors:  R Singal; G D Ginder
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

2.  CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.

Authors:  S Zupo; L Isnardi; M Megna; R Massara; F Malavasi; M Dono; E Cosulich; M Ferrarini
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

3.  Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors.

Authors:  T Kinoshita; K Koike; H H Mwamtemi; S Ito; S Ishida; Y Nakazawa; Y Kurokawa; K Sakashita; T Higuchi; K Takeuchi; N Sawai; M Shiohara; T Kamijo; S Kawa; T Yamashita; A Komiyama
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

4.  p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing.

Authors:  E E Cameron; S B Baylin; J G Herman
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

5.  Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.

Authors:  J Schwaller; T Pabst; H P Koeffler; G Niklaus; P Loetscher; M F Fey; A Tobler
Journal:  Leukemia       Date:  1997-01       Impact factor: 11.528

6.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

Review 7.  DNA methylation in early development.

Authors:  A Razin; R Shemer
Journal:  Hum Mol Genet       Date:  1995       Impact factor: 6.150

8.  Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation.

Authors:  A F Lois; L T Cooper; Y Geng; T Nobori; D Carson
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

9.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.

Authors:  J G Herman; J Jen; A Merlo; S B Baylin
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701

10.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

Authors:  G J Hannon; D Beach
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

View more
  9 in total

1.  p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia.

Authors:  K P Ng; Q Ebrahem; S Negrotto; R Z Mahfouz; K A Link; Z Hu; X Gu; A Advani; M Kalaycio; R Sobecks; M Sekeres; E Copelan; T Radivoyevitch; J Maciejewski; J C Mulloy; Y Saunthararajah
Journal:  Leukemia       Date:  2011-06-24       Impact factor: 11.528

2.  Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.

Authors:  Thomas A Paul; Juraj Bies; Donald Small; Linda Wolff
Journal:  Blood       Date:  2010-02-26       Impact factor: 22.113

Review 3.  DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Authors:  Björn Rüter; Pierre W Wijermans; Michael Lübbert
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

4.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

Authors:  Ramiro Garzon; Shujun Liu; Muller Fabbri; Zhongfa Liu; Catherine E A Heaphy; Elisa Callegari; Sebastian Schwind; Jiuxia Pang; Jianhua Yu; Natarajan Muthusamy; Violaine Havelange; Stefano Volinia; William Blum; Laura J Rush; Danilo Perrotti; Michael Andreeff; Clara D Bloomfield; John C Byrd; Kenneth Chan; Lai-Chu Wu; Carlo M Croce; Guido Marcucci
Journal:  Blood       Date:  2009-02-11       Impact factor: 22.113

5.  In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.

Authors:  K Sakashita; I Kato; T Daifu; S Saida; H Hiramatsu; Y Nishinaka; Y Ebihara; F Ma; K Matsuda; S Saito; K Hirabayashi; T Kurata; L T N Uyen; Y Nakazawa; K Tsuji; T Heike; T Nakahata; K Koike
Journal:  Leukemia       Date:  2014-08-08       Impact factor: 11.528

6.  Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia.

Authors:  Robert J Weeks; Ursula R Kees; Sarah Song; Ian M Morison
Journal:  Mol Cancer       Date:  2010-06-24       Impact factor: 27.401

7.  An integrative analysis of DNA methylation and RNA-Seq data for human heart, kidney and liver.

Authors:  Linglin Xie; Brent Weichel; Joyce Ellen Ohm; Ke Zhang
Journal:  BMC Syst Biol       Date:  2011-12-23

8.  Epigenomic-basis of Preemptive Medicine for Neurodevelopmental Disorders.

Authors:  Takeo Kubota; Kunio Miyake; Natsuyo Hariya; Kazuki Mochizuki
Journal:  Curr Genomics       Date:  2015-06       Impact factor: 2.236

9.  Epigenetic Modifications of the PGC-1α Promoter during Exercise Induced Expression in Mice.

Authors:  Timothy L Lochmann; Ravindar R Thomas; James P Bennett; Shirley M Taylor
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.